Latest news with #SLQT
Yahoo
14-05-2025
- Business
- Yahoo
Why SelectQuote Stock Got Slammed Today
The company unveiled its latest set of quarterly earnings. It showed robust growth, but a Department of Justice complaint is dogging its stock. 10 stocks we like better than SelectQuote › Veteran health insurance broker SelectQuote (NYSE: SLQT) wasn't quite looking like the wave of the future on Monday. The company's shares took a 12% hit on the day, following management's release of the latest set of quarterly figures. That was in rather sharp contrast to the overall stock market, where the benchmark S&P 500 index rose by a relatively steep 3.3%. For its fiscal third quarter of 2025, SelectQuote reaped just over $408 million in total revenue, up from the more than $376 million it earned in the same period of fiscal 2024. Generally accepted accounting principles (GAAP) net income came in at over $26 million ($0.03 per share), more than triple the under-$8.6 million profit of the year-ago period. Although those increases were nothing to sneeze at, the company missed on the bottom line, if only slightly. On average, analysts tracking SelectQuote stock were modeling $0.04 per share net income. The company did beat on revenue, however, as the average pundit estimate was a bit over $402 million. In its earnings release, SelectQuote quoted CEO Tim Danker as saying that "SelectQuote's agent-led model paired with our technology-enabled information advantage made our platform more valuable than ever to participants in the healthcare ecosystem." However, investors might have been more concerned with what SelectQuote and its management team didn't say. In the earnings release, it didn't further address allegations brought by the government's Department of Justice (DoJ) in a complaint that the company -- along with peer health insurance brokers -- accepted illegal "kickback" payments by top insurers. That, despite the fact that SelectQuote issued a press release Friday saying that it "strongly disagrees" with the allegations. It also vowed to defend itself against the DoJ's accusations, predicting a positive outcome for it in the case. Before you buy stock in SelectQuote, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and SelectQuote wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $614,911!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $714,958!* Now, it's worth noting Stock Advisor's total average return is 907% — a market-crushing outperformance compared to 163% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 12, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why SelectQuote Stock Got Slammed Today was originally published by The Motley Fool
Washington Post
12-05-2025
- Business
- Washington Post
SelectQuote: Fiscal Q3 Earnings Snapshot
OVERLAND PARK, Kan. — OVERLAND PARK, Kan. — SelectQuote, Inc. (SLQT) on Monday reported net income of $26 million in its fiscal third quarter. The Overland Park, Kansas-based company said it had profit of 3 cents per share. The company posted revenue of $408.2 million in the period. SelectQuote expects full-year revenue in the range of $1.5 billion to $1.58 billion.
Yahoo
12-05-2025
- Business
- Yahoo
SelectQuote: Fiscal Q3 Earnings Snapshot
OVERLAND PARK, Kan. (AP) — OVERLAND PARK, Kan. (AP) — SelectQuote, Inc. (SLQT) on Monday reported net income of $26 million in its fiscal third quarter. The Overland Park, Kansas-based company said it had profit of 3 cents per share. The company posted revenue of $408.2 million in the period. SelectQuote expects full-year revenue in the range of $1.5 billion to $1.58 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SLQT at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
07-05-2025
- Business
- Associated Press
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation's largest health insurance companies, claiming violations of the False Claims Act. Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. SelectQuote (SLQT) Investigation: The investigation is focused on the propriety of SelectQuote's disclosures concerning its sales and other business practices, particularly with respect to its Senior business which offers Medicare Advantage ('MA') plans written by health insurance companies such as Aetna, Anthem, and Humana ('insurers'). In the past, SelectQuote has claimed '[o]ur agents are trained to offer unbiased advice in order to be more aligned to the specific needs of each customer' and Senior 'provides unbiased comparison shopping for Medicare Advantage ('MA') and Medicare Supplement ('MS') insurance plans[.]' SelectQuote's claims came into question on May 1, 2025, when the DOJ filed a complaint alleging that from 2016 through at least 2021 the insurers: Paid hundreds of millions of dollars to SelectQuote and other brokers in exchange for enrollments into the insurers' Medicare Advantage plans; Rather than acting as unbiased stewards, SelectQuote and other brokers directed Medicare beneficiaries to the plans offered by insurers that paid brokers the most in kickbacks, regardless of the suitability of the MA plans for the beneficiaries; SelectQuote and other brokers incentivized their employees and agents to sell plans based on the insurers' kickbacks, set up teams of insurance agents who could sell only those plans, and at times refused to sell MA plans of insurers who did not pay sufficient kickbacks; and SelectQuote and other brokers conspired to discriminate against MA beneficiaries with disabilities. This news sent SelectQuote shares spiraling 19% lower on May 1, 2025. 'We're concerned about SelectQuote's alleged steering practices and the extent to which the practices, if true, may have inflated the company's financial results,' said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in SelectQuote and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now » If you'd like more information and answers to frequently asked questions about the SelectQuote investigation, read more» Whistleblowers: Persons with non-public information regarding SelectQuote should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected]. About Hagens Berman Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at Follow the firm for updates and news at @ClassActionLaw. Contact: Reed Kathrein, 844-916-0895
Business Wire
02-05-2025
- Business
- Business Wire
Securities Fraud Investigation Into SelectQuote, Inc. (SLQT) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces an investigation of SelectQuote, Inc. ('SelectQuote' or the 'Company') (NYSE: SLQT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SELECTQUOTE, INC. (SLQT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 1, 2025, the U.S. Department of Justice ("DOJ") filed a False Claims Act complaint against SelectQuote, alleging that 'from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers' Medicare Advantage plans." On this news, SelectQuote's stock price fell $0.61, or 19.2%, to close at $2.56 per share on May 1, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased SelectQuote securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
